Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke ...

"Many supplements have real biologic effects, and when you layer them on top of blood thinners, you can tip into either ...

More than 8 million people in the U.S. take blood thinners to prevent dangerous clots. At the same time, the drugs are ...

FDA-approved Andexxa reversed Xarelto and Eliquis bleeding but was linked to higher rates of blood clots and death, ...

Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy ...

Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was ...

By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue, ...

Bristol Myers Squibb on Thursday forecast 2026 revenue and profit above Wall Street estimates, saying that price cuts to its ...

Christian Barmore was diagnosed with life-threatening blood clots in 2024 but returned to play every game this season under ...

UnitedHealth is the largest U.S.-based managed health care firm, providing health plans and health care services to a wide range of customers. The company’s operations include its UnitedHealthcare ...

(The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage ...

Bristol-Myers Squibb and Pfizer filed a patent infringement lawsuit against Azurity Pharmaceuticals on Dec. 23 in Delaware District Court over the blood thinner medication Eliquis. The action, brought ...